Crossref
Novo Nordisk taps start-up for new oral weight-loss drugs
C&EN Global Enterprise · 23.03.2026 · 104 (4) · 17-17
DOI: 10.1021/cen-10404-buscon4 ↗Kurz gefasst
Fachartikel in der Zeitschrift C&EN Global Enterprise, online erschienen am 23.03.2026. Verfasst von Rowan Walrath.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Walrath, R. (2026). Novo Nordisk taps start-up for new oral weight-loss drugs. C&EN Global Enterprise, 104(4), 17-17. https://doi.org/10.1021/cen-10404-buscon4
Vancouver
Walrath R. Novo Nordisk taps start-up for new oral weight-loss drugs. C&EN Global Enterprise. 2026;104(4):17-17. doi:10.1021/cen-10404-buscon4
BibTeX
@article{Walrath2026,
author = {Walrath, Rowan},
title = {Novo Nordisk taps start-up for new oral weight-loss drugs},
journal = {C&EN Global Enterprise},
year = {2026},
volume = {104},
number = {4},
pages = {17--17},
doi = {10.1021/cen-10404-buscon4}
}
EUVIMED